Top Story

Adjuvant chemotherapy associated with shorter survival in LCNEC

April 27, 2015

SEATTLE — Patients who underwent adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinomas demonstrated poorer 3-year survival than those who did not undergo adjuvant treatment, according to study results presented at the American Association for Thoracic Surgery Annual Meeting.

“We did not see any particular subset of patients who may benefit from this treatment,” researcher Pier Luigi Filosso, MD, of the University of Torino in Italy, said during a presentation.

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder Meeting News CoverageVideo

VIDEO: T-cell immunotherapy may induce durable remissions in post-HSCT lymphoproliferative disorder

April 27, 2015
Richard J. O’Reilly, MD, chairman of the department of pediatrics at Memorial Sloan Kettering Cancer Center, provides an overview of trials evaluating a large…
Medicare’s new payment system gives physicians two options Health Care Legislative and Regulatory Update

Medicare’s new payment system gives physicians two options

April 27, 2015
The Medicare Access and CHIP Reauthorization Act, signed into law on April 16, will make major changes in Medicare payments for physician services. Things start out…
In the Journals

Millions have died worldwide due to lack of access to surgical care, anesthesia

April 27, 2015
Nearly 5 billion people, primarily those in low- to middle-income countries, do not have access to safe surgical and anesthesia care, resulting in 16.9 million…
In the Journals

Researchers identify risk factors for development of pancreatic cancer

April 27, 2015
A team of international researchers developed a profile identifying risk factors for malignancy progression in intraductal papillary mucinous neoplasms of the…
More News Headlines »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
VIDEO: Ipilimumab plus nivolumab conferred high response rates in melanoma

VIDEO: Ipilimumab plus nivolumab conferred high response rates in melanoma

April 27, 2015
F. Stephen Hodi, Jr., MD, director of the melanoma center at Dana-Farber Cancer Institute and associate professor of…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
morganatic-roan
morganatic-roan